Results 21 to 30 of about 96,218 (256)

An apology for beta blockers

Journal of Hepatology, 2014
might have stumbled across other rather informative (and much We read with interest the recent review on beta-blockers in cirrhosis by Ge and Runyon [1]. This topic is of great importance, as non-selective beta blockers are a pharmacological mainstay in the management of patients with cirrhosis; the amount of evidence has been increasing substantially ...
Thalheimer, Ulrich, Bosch, Jaime, Burroughs, Andrew K.   +2 more
openaire   +2 more sources

Current patterns of beta‐blocker prescription in cardiac amyloidosis: an Italian nationwide survey

ESC Heart Failure, 2021
Aims The use of beta‐blocker therapy in cardiac amyloidosis (CA) is debated. We aimed at describing patterns of beta‐blocker prescription through a nationwide survey.
Giacomo Tini, Francesco Cappelli, Elena Biagini, Beatrice Musumeci, Marco Merlo, Lia Crotti, Matteo Cameli, Gianluca Di Bella, Alberto Cipriani, Francesca Marzo, Federico Guerra, Cinzia Forleo, Christian Gagliardi, Mattia Zampieri, Samuela Carigi, Pier Filippo Vianello, Giulia Elena Mandoli, Giuseppe Ciliberti, Luca Lichelli, Davide Mariani, Aldostefano Porcari, Domitilla Russo, Roberto Licordari, Alberto Ponziani, Italo Porto, Federico Perfetto, Camillo Autore, Claudio Rapezzi, Giafranco Sinagra, Marco Canepa   +29 more
doaj   +1 more source

Efficacy of beta-blocker therapy in symptomatic athletes with exercise-induced intra-ventricular gradients

Cardiovascular Ultrasound, 2010
Background Upright exercise stress echocardiography (SE) induces significant intraventricular gradient (IVG) and systolic anterior motion (SAM) in a large proportion of symptomatic athletes, who may therefore benefit from a negative inotropic therapy ...
Cotrim Carlos, Lopes Luís R, Almeida Ana R, Miranda Rita, Ana Almeida G, Cotrim Hortense, Andrade José P, Picano Eugenio, Carrageta Manuel   +8 more
doaj   +1 more source

The association between beta-blocker use and chronic obstructive pulmonary disease risk, severity, and exacerbation

Medical Journal of Babylon, 2021
Background: There is controversy about the role of beta-blockers in the number of acute exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Hemin Khalid Saber
doaj   +1 more source

Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy

Journal of Ophthalmology, 2017
Objective. To evaluate the efficacy and tolerability of travoprost 0.004%/timolol 0.5% fixed-dose combination (TTFC) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT) inadequately controlled on beta-blocker monotherapy. Methods.
Simon Fabian Lerner, Ki Ho Park, Douglas A. Hubatsch, Valeriy Erichev, Jose A. Paczka, Timothy V. Roberts   +5 more
doaj   +1 more source

The role of plasma concentrations and drug characteristics of beta‐blockers in fall risk of older persons

Pharmacology Research & Perspectives, 2023
Beta‐blocker usage is inconsistently associated with increased fall risk in the literature. However, due to age‐related changes and interindividual heterogeneity in pharmacokinetics and dynamics, it is difficult to predict which older adults are more at ...
K. J. Ploegmakers, E. P. vanPoelgeest, L. J. Seppala, S. C. vanDijk, L. C. P. G. M. deGroot, S. Oliai Araghi, N. M. vanSchoor, B. Stricker, K. M. A. Swart, A. G. Uitterlinden, R. A. A. Mathôt, N. van derVelde   +11 more
doaj   +1 more source

THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS

Рациональная фармакотерапия в кардиологии, 2016
Basic principles of beta-blockers choice strategy are presented. Attention is focused on the facts concerning the evidence base for effects of various beta-blockers on the outcomes of cardiovascular diseases.
S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina   +2 more
doaj   +1 more source

Evaluation of Perioperative Beta-Blockers and Factors Associated with Postoperative Atrial Fibrillation in Cardiac Surgery: A Single Center Experience

Reviews in Cardiovascular Medicine, 2023
Background: Postoperative atrial fibrillation (AF) has a complex etiology, and beta-blockers are commonly recommended for its pharmacological prevention.
Alexandra Puscas, Marius M. Harpa, Klara Brinzaniuc, Hussam Al-Hussein, Hamida Al-Hussein, Cosmin Banceu, Carmen Opris, Claudiu Ghiragosian, Sanziana Flamind, Robert Balan, Septimiu Voidazan, Horatiu Suciu   +11 more
doaj   +1 more source

Preoperative beta-blocker in ventricular dysfunction patients: need a more granular quality metric

BMC Cardiovascular Disorders, 2021
Background The use of preoperative beta-blockers has been accepted as a quality standard for patients undergoing coronary artery bypass graft (CABG) surgery.
Hanwei Tang, Kai Chen, Jianfeng Hou, Xiaohong Huang, Sheng Liu, Shengshou Hu   +5 more
doaj   +1 more source

Beta-Blocker-Related Atrioventricular Conduction Disorders—A Single Tertiary Referral Center Experience

Medicina, 2022
Background and Objectives: Drug-related bradyarrhythmia is a well-documented major adverse event among beta-blocker users and a potential cause for hospitalization or additional interventions.
Dragoș Traian Marius Marcu, Cristina Andreea Adam, Dan-Mihai Dorobanțu, Delia Lidia Șalaru, Radu Andy Sascău, Mircea Ovanez Balasanian, Liviu Macovei, Cătălina Arsenescu-Georgescu, Cristian Stătescu   +8 more
doaj   +1 more source